Interactions of cholesterol molecules with GPCRs in different states: A comparative analysis of GPCRs' structures

https://doi.org/10.1016/j.bbamem.2022.184100Get rights and content
Under an Elsevier user license
open archive

Highlights

  • The positions of cholesterol molecules in structures of 68 GPCRs in different states are gathered in an interactive table

  • A comparative analysis of CLR number and position is performed between different states of GPCR

  • Cholesterol molecules bind differently when some GPCRs adopt a ligand-bound state

  • The type of ligands and intracellular binders affect the interaction of CLR in several GPCR structures

Abstract

GPCRs form a very large family of transmembrane proteins involved in a wide range of physiological functions. Some GPCRs have their activity affected by the presence of cholesterol either indirectly through changes in the physical properties of the membrane or directly by binding to the receptor. Thanks to recent advances in structural biology, many structures of GPCRs have been solved, 240 of which contain at least one cholesterol molecule or surrogate. This review lists the position of these molecules and provides a comparative analysis of the changes observed in the structures depending on the state of the receptor.

Keywords

GPCRs
Structures
Cholesterol
Interaction
Protein/lipid
Database

Abbreviations

GPCR
G protein-coupled receptor
CLR
cholesterol molecule
CHS
cholesteryl hemisuccinate
PDB ID
protein databank identifier
CRAC
cholesterol recognition/interaction amino acid consensus
CCM
cholesterol consensus motif
MD
molecular dynamics
TM
transmembrane helix
PAM
positive allosteric modulator
NAM
negative allosteric modulator
cryo-EM
cryo-electron microscopy
FIB-SEM
focused ion beam scanning electron microscopy
ECL
extracellular loop

Cited by (0)

1

Present address: Domainex, Iconix 2, Unity Campus, London Road, Pampisford, Cambridge CB22 3EG, UK.

2

Present address: Domain Therapeutics, Bioparc, 850 Boulevard Sébastien Brant 67400 Illkirch, France.